Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2026-05-04 @ 3:09 PM
Study NCT ID:
NCT02243358
Status:
COMPLETED
Last Update Posted:
2023-10-27
First Post:
2014-09-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Sponsor:
Henry Ford Health System
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HFHS 13-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None